Next Financial Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $4.21M | Buy |
58,054
+1,471
| +3% | +$101K | 0.28% | 71 |
|
|
2021
Q3 | $3.95M | Buy |
56,583
+3,783
| +7% | +$266K | 0.31% | 66 |
|
|
2021
Q2 | $3.64M | Buy |
52,800
+34,067
| +182% | +$2.27M | 0.29% | 69 |
|
|
2021
Q1 | $1.21M | Sell |
18,733
-3,240
| -15% | -$209K | 0.11% | 210 |
|
|
2020
Q4 | $1.28M | Buy |
21,973
+3,097
| +16% | +$187K | 0.12% | 170 |
|
|
2020
Q3 | $1.19M | Sell |
18,876
-5,195
| -22% | -$360K | 0.13% | 170 |
|
|
2020
Q2 | $1.85M | Buy |
24,071
+6,067
| +34% | +$465K | 0.22% | 120 |
|
|
2020
Q1 | $1.35M | Buy |
18,004
+8,539
| +90% | +$590K | 0.17% | 126 |
|
|
2019
Q4 | $615K | Sell |
9,465
-19,485
| -67% | -$1.27M | 0.06% | 321 |
|
|
2019
Q3 | $1.83M | Sell |
28,950
-7,127
| -20% | -$466K | 0.2% | 121 |
|
|
2019
Q2 | $2.44M | Buy |
36,077
+35,202
| +4,023% | +$2.32M | 0.26% | 82 |
|
|
2019
Q1 | $57K | Sell |
875
-5,271
| -86% | -$350K | 0.01% | 694 |
|
|
2018
Q4 | $384K | Buy |
6,146
+2,874
| +88% | +$201K | 0.08% | 260 |
|
|
2018
Q3 | $253K | Sell |
3,272
-1,467
| -31% | -$111K | 0.12% | 172 |
|
|
2018
Q2 | $336K | Sell |
4,739
-2,200
| -32% | -$155K | 0.13% | 181 |
|
|
2018
Q1 | $523K | Buy |
6,939
+2,974
| +75% | +$236K | 0.11% | 199 |
|
|
2017
Q4 | $284K | Sell |
3,965
-2,127
| -35% | -$162K | 0.12% | 199 |
|
|
2017
Q3 | $494K | Sell |
6,092
-10,508
| -63% | -$804K | 0.14% | 166 |
|
|
2017
Q2 | $1.18M | Buy |
16,600
+7,072
| +74% | +$471K | 0.29% | 87 |
|
|
2017
Q1 | $653K | Sell |
9,528
-3,687
| -28% | -$259K | 0.18% | 127 |
|
|
2016
Q4 | $946K | Sell |
13,215
-1,657
| -11% | -$123K | 0.17% | 143 |
|
|
2016
Q3 | $1.18M | Buy |
14,872
+3,265
| +28% | +$265K | 0.21% | 112 |
|
|
2016
Q2 | $968K | Sell |
11,607
-603
| -5% | -$53.5K | 0.31% | 79 |
|
|
2016
Q1 | $1.12M | Buy |
12,210
+1,321
| +12% | +$119K | 0.4% | 61 |
|
|
2015
Q4 | $1.1M | Buy |
10,889
+183
| +2% | +$19K | 0.41% | 57 |
|
|
2015
Q3 | $1.05M | Sell |
10,706
-1,601
| -13% | -$178K | 0.38% | 63 |
|
|
2015
Q2 | $1.44M | Sell |
12,307
-160
| -1% | -$17.5K | 0.5% | 43 |
|
|
2015
Q1 | $1.22M | Sell |
12,467
-59
| -0.5% | -$5.99K | 0.39% | 66 |
|
|
2014
Q4 | $1.18M | Sell |
12,526
-4,190
| -25% | -$433K | 0.39% | 57 |
|
|
2014
Q3 | $1.78M | Buy |
16,716
+14,184
| +560% | +$1.39M | 0.35% | 52 |
|
|
2014
Q2 | $234K | Buy |
+2,532
| New | +$197K | 0.12% | 140 |
|
Other funds holding GILD
Next Financial Group's GILD Position: Q4 2021 in Review
Next Financial Group increased its Gilead Sciences (GILD) stake by 2.6% in Q4 2021, buying an estimated $101K and bringing the position to 58,054 shares worth $4.21M. The position accounts for 0.28% of the portfolio, ranked #71.
Next Financial Group first reported a position in GILD in Q2 2014 and has held it in 31 quarters since. 1,682 funds tracked by Wall St. Rank hold GILD as of Q4 2021.
- Next Financial Group held 58,054 shares of Gilead Sciences worth $4.21M as of Q4 2021.
- Next Financial Group bought 1,471 Gilead Sciences shares in Q4 2021, an estimated $101K.
- Gilead Sciences made up 0.28% of Next Financial Group's portfolio in Q4 2021, its #71 holding.
- Next Financial Group first reported a position in Gilead Sciences in Q2 2014 and has held it in 31 quarters since.
- 1,682 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2021.
Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.